Delivered by Cyntia Genolet, Senior Manager Global Health Policy, IFPMA Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world, including three in Africa. The IFPMA welcomes the WHO’s ambitious 13 General Programme of Work, which...
Read moreDelivered by Cyntia Genolet, Senior Manager Global Health Policy, IFPMA Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world, including three in Africa. The IFPMA notes the report and agrees with the proposed actions, specifically...
Read moreThis blog piece has been first published in Africa Health Journal, July 2018 Latest Ebola response holds key to global health security Thomas Cueni discusses the important role of immunisation and the critical role of the pharmaceutical industry in combatting new threats such as with Ebola The recent deadly outbreak of Ebola virus disease (EVD)...
Read moreThis letter was first published on the Financial Times on 4th July 2018, in response to the article titled “Pharma sector failing to tackle superbugs, says O’Neill” (26th June 2018) I respectfully disagree with Jim O’Neill’s comments on pharmaceutical companies’ inaction on combating antimicrobial resistance (“ Pharma sector failing to tackle superbugs, says O’Neill”,...
Read moreThis blog was first published on the Media Planet supplement for the Guardian on 27 June 2018 Last month, President Kagame told the World Health Assembly: “In Rwanda, a combination of community-based health insurance, community health workers, and good external partnerships led to the steepest reductions (a halving) in child and maternal mortality ever...
Read more28 May 2018, Geneva – IFPMA, the voice of the biopharmaceutical innovation and health progress around the world, made a series of statements during the 71st World Health Assembly. As the Assembly kicked off, IFPMA called for even greater collaboration as being critical to future global health progress. In his inaugural and closing remarks, Dr...
Read more25 May 2018 Statement delivered by Paula Barbosa, IFPMA, Manager, Vaccines Policy Mr Chairman, IFPMA and its member companies would like to confirm our continued collaboration in the context of pandemic preparedness and response efforts. Through the PIP Framework, influenza vaccine and antiviral manufacturers have helped the WHO secure 405 million doses of influenza...
Read moreIFPMA welcomes the organization of the High-Level Meeting on ending Tuberculosis and WHO’s progress in developing a draft multisectoral accountability framework to accelerate countries’ engagement to reach the goals of the “End TB” strategy and the TB targets of the of the Sustainable Development Goals. The pharmaceutical industry is committed to contribute to...
Read more